Drugs / FBF001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02295813 | Oct → Dec 2012 | avian influenza | Fab'entech | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FBF001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02295813 ↗ |
| Modality | Protein / enzyme biologic | “specific polyclonal immunoglobulin equine F(ab')₂ fragments” PMID 25662592 ↗ Feb 2015 |
| Route | Intravenous | “once-daily intravenous infusions of 0·85 U/kg body weight of F(ab')₂” PMID 25662592 ↗ Feb 2015 |